Edition:
United States

Bristol-Myers Squibb Co (BMY)

BMY on New York Consolidated

76.47USD
27 Jul 2016
Change (% chg)

$1.41 (+1.88%)
Prev Close
$75.06
Open
$75.20
Day's High
$76.80
Day's Low
$75.01
Volume
5,542,648
Avg. Vol
5,745,260
52-wk High
$77.12
52-wk Low
$51.82

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.64 December 27 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 7 7 7
(2) OUTPERFORM 6 6 6 6
(3) HOLD 9 9 9 8
(4) UNDERPERFORM 1 1 1 1
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.29 2.29 2.29 2.26

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 17 4,695.93 4,918.00 4,551.48 4,078.49
Quarter Ending Dec-16 17 4,897.70 5,188.00 4,701.00 4,339.78
Year Ending Dec-16 23 18,567.80 19,292.00 17,385.00 16,614.10
Year Ending Dec-17 23 20,818.30 22,122.00 19,358.00 18,569.00
Earnings (per share)
Quarter Ending Sep-16 20 0.64 0.68 0.57 0.57
Quarter Ending Dec-16 20 0.57 0.65 0.48 0.51
Year Ending Dec-16 25 2.58 2.74 2.20 2.25
Year Ending Dec-17 25 3.24 3.70 2.57 2.93
LT Growth Rate (%) 8 23.21 31.63 18.80 18.41

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 4,249.39 4,391.00 141.61 3.33
Quarter Ending Dec-15 4,148.85 4,287.00 138.15 3.33
Quarter Ending Sep-15 3,855.72 4,069.00 213.28 5.53
Quarter Ending Jun-15 3,706.16 4,163.00 456.84 12.33
Quarter Ending Mar-15 3,808.29 4,041.00 232.71 6.11
Earnings (per share)
Quarter Ending Mar-16 0.65 0.74 0.09 14.60
Quarter Ending Dec-15 0.28 0.38 0.10 33.61
Quarter Ending Sep-15 0.35 0.39 0.04 11.17
Quarter Ending Jun-15 0.36 0.53 0.17 46.13
Quarter Ending Mar-15 0.51 0.71 0.20 40.21

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 4,695.93 4,698.71 4,674.20 4,671.08 4,078.49
Quarter Ending Dec-16 4,897.70 4,903.61 4,891.95 4,892.26 4,339.78
Year Ending Dec-16 18,567.80 18,575.50 18,494.50 18,539.50 16,614.10
Year Ending Dec-17 20,818.30 20,826.40 20,783.10 20,766.30 18,569.00
Earnings (per share)
Quarter Ending Sep-16 0.64 0.64 0.64 0.63 0.57
Quarter Ending Dec-16 0.57 0.57 0.56 0.56 0.51
Year Ending Dec-16 2.58 2.58 2.56 2.57 2.25
Year Ending Dec-17 3.24 3.24 3.22 3.21 2.93

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 1 2 6 4
Quarter Ending Dec-16 1 2 5 5
Year Ending Dec-16 1 2 8 7
Year Ending Dec-17 1 2 8 7
Earnings
Quarter Ending Sep-16 0 1 4 4
Quarter Ending Dec-16 1 1 7 4
Year Ending Dec-16 1 1 10 3
Year Ending Dec-17 1 1 6 3

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.